Atorvastatin Calcium Tablets (Lipitor) are lipid-lowering drugs belonging to the HMG-CoA reductase inhibitor class. They hold significant clinical value in the treatment of hypercholesterolemia and familial hypercholesterolemia. As strictly regulated prescription drugs, their acquisition and use must comply with specific guidelines.

What Are the Purchase Channels for Atorvastatin Calcium Tablets (Lipitor)?

Overseas Purchase

Patients may choose to consult and purchase the drug at hospital pharmacies or legitimate drugstores in countries or regions where Atorvastatin Calcium Tablets have been launched.

Since drug prices may be affected by factors such as regional differences and exchange rate fluctuations, patients need to make a budget and plan in advance before purchasing.

Purchase Through Medical Service Institutions

Patients may consult domestic overseas medical service institutions that cooperate with international pharmacies or pharmaceutical companies.

These institutions usually provide legal import channels and can offer professional consultation and guidance.

Precautions for Purchase and Use of Atorvastatin Calcium Tablets (Lipitor)

Prescription and Dosage Management

Standard dosage: The usual starting dose for adults is 10 mg orally once daily, which can be adjusted according to the patient’s condition.

Maximum dosage: For patients with severe hypercholesterolemia, the dose can be increased to 20 mg per day; for patients with familial hypercholesterolemia, the dose can be increased to 40 mg per day.

Administration time: Take the drug at a fixed time every day, without being affected by meals.

Warnings for Contraindicated Populations

Patients with a history of allergy to the ingredients of this drug.

Patients with severely impaired liver function, such as acute hepatitis, acute exacerbation of chronic hepatitis, liver cirrhosis, liver cancer, and jaundice.

Pregnant women, women who may become pregnant, and lactating women.

Patients currently using glecaprevir/pibrentasvir.

Medication Restrictions for Special Populations

Hepatic impairment: Dosage adjustment is required for patients with moderate hepatic impairment (Child-Pugh Class B); use is contraindicated in patients with severe hepatic impairment.

Renal impairment: Extreme caution is needed when combining with fibrate drugs such as bezafibrate.

Elderly patients: Due to age-related decline in physiological functions, enhanced medication monitoring is required.

Authenticity Identification of Atorvastatin Calcium Tablets (Lipitor)

Characteristics of the 5 mg Strength

Appearance: Very pale red film-coated tablets.

Size: 5.6 mm in diameter, 2.7 mm in thickness.

Weight: 72 mg.

Identification code: VT715.

Characteristics of the 10 mg Strength

Appearance: White film-coated tablets.

Size: 6.1 mm in diameter, 2.7 mm in thickness.

Weight: 88 mg.

Identification code: VT716.

Identification of Abnormal Quality

Changes in properties: If abnormal tablet color or moisture-induced caking is found, discontinue use immediately.

Storage conditions: Store at room temperature; pay attention to moisture prevention after opening the package.